Biochanin A Induces S Phase Arrest and Apoptosis in Lung Cancer Cells
Authors:
Open Access
- 3 October 2018
- journal article
- research article
- Published by Wiley in BioMed Research International
- Vol. 2018, 1-12
Abstract
Lung cancer is among the most common malignancies with a poor 5-year survival rate reaching only 16%. Thus, new effective treatment modalities and drugs are urgently needed for the treatment of this malignancy. In this study, we conducted the first investigation of the effects of Biochanin A on lung cancer and revealed the mechanisms underlying its potential anticancer effects. Biochanin A decreased cell viability in a time-dependent and dose-dependent manner and suppressed colony formation in A549 and 95D cells. In addition, Biochanin A induced S phase arrest and apoptosis and decreased mitochondrial membrane potential (ΔΨm) in A549 and 95D cells in a dose-dependent manner. Our results of subcutaneous xenograft models showed that the growth of Biochanin A group was significantly inhibited compared with that of control groups. Finally, P21, Caspase-3, and Bcl-2 were activated in Biochanin A-treated cells and Biochanin A-treated xenografts which also demonstrated that Biochanin A induced cell cycle arrest and apoptosis in lung cancer cells by regulating expression of cell cycle-related proteins and apoptosis-related proteins. In conclusion, this study suggests that Biochanin A inhibits the proliferation of lung cancer cells and induces cell cycle arrest and apoptosis mainly by regulating cell cycle-related protein expression and activating the Bcl-2 and Caspase-3 pathways, thus suggesting that Biochanin A may be a promising drug to treat lung cancer.Keywords
This publication has 34 references indexed in Scilit:
- Curcumin induces apoptosis in gallbladder carcinoma cell line GBC-SD cellsCancer Cell International, 2013
- Deciphering the rules of programmed cell death to improve therapy of cancer and other diseasesThe EMBO Journal, 2011
- Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012Cell Death & Differentiation, 2011
- The role of Bcl-2 and its pro-survival relatives in tumourigenesis and cancer therapyCell Death & Differentiation, 2011
- Aberrant methylation in promoter regions of cyclin‐dependent kinase inhibitor genes in adenoid cystic carcinoma of the salivary glandAPMIS, 2008
- Estimates of the cancer incidence and mortality in Europe in 2006Annals of Oncology, 2007
- Mitochondrial Membrane Permeabilization in Cell DeathPhysiological Reviews, 2007
- Recycling the Cell CycleCell, 2004
- Induction of cell-cycle arrest and apoptosis by a novel retinobenzoic-acid derivative, TAC-101, in human pancreatic-cancer cellsInternational Journal of Cancer, 1999
- Genistein inhibition of the growth of human breast cancer cells: Independence from estrogen receptors and the multi-drug resistance geneBiochemical and Biophysical Research Communications, 1991